Preclinical evidence for the therapeutic value of TBX5 normalization in arrhythmia control

Arrhythmias and sudden cardiac death (SCD) occur commonly in patients with heart failure. We found T-box 5 (TBX5) dysregulated in ventricular myocardium from heart failure patients and thus we hypothesized that TBX5 reduction contributes to arrhythmia development in these patients. To understand the...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Rathjens, Franziska S. (VerfasserIn) , Blenkle, Alica (VerfasserIn) , Iyer, Lavanya M (VerfasserIn) , Renger, Anke (VerfasserIn) , Syeda, Fahima (VerfasserIn) , Noack, Claudia (VerfasserIn) , Jungmann, Andreas (VerfasserIn) , Dewenter, Matthias (VerfasserIn) , Toischer, Karl (VerfasserIn) , El-Armouche, Ali (VerfasserIn) , Müller, Oliver J. (VerfasserIn) , Fabritz, Larissa (VerfasserIn) , Zimmermann, Wolfram-Hubertus (VerfasserIn) , Zelarayan, Laura C (VerfasserIn) , Zafeiriou, Maria-Patapia (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2021
In: Cardiovascular research
Year: 2021, Jahrgang: 117, Heft: 8, Pages: 1908-1922
ISSN:1755-3245
DOI:10.1093/cvr/cvaa239
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1093/cvr/cvaa239
Volltext
Verfasserangaben:Franziska S Rathjens, Alica Blenkle, Lavanya M Iyer, Anke Renger, Fahima Syeda, Claudia Noack, Andreas Jungmann, Matthias Dewenter, Karl Toischer, Ali El-Armouche, Oliver J Müller, Larissa Fabritz, Wolfram-Hubertus Zimmermann, Laura C Zelarayan, and Maria-Patapia Zafeiriou

MARC

LEADER 00000caa a2200000 c 4500
001 1796310611
003 DE-627
005 20231019143511.0
007 cr uuu---uuuuu
008 220322s2021 xx |||||o 00| ||eng c
024 7 |a 10.1093/cvr/cvaa239  |2 doi 
035 |a (DE-627)1796310611 
035 |a (DE-599)KXP1796310611 
035 |a (OCoLC)1341446163 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Rathjens, Franziska S.  |e VerfasserIn  |0 (DE-588)1253924260  |0 (DE-627)1796310670  |4 aut 
245 1 0 |a Preclinical evidence for the therapeutic value of TBX5 normalization in arrhythmia control  |c Franziska S Rathjens, Alica Blenkle, Lavanya M Iyer, Anke Renger, Fahima Syeda, Claudia Noack, Andreas Jungmann, Matthias Dewenter, Karl Toischer, Ali El-Armouche, Oliver J Müller, Larissa Fabritz, Wolfram-Hubertus Zimmermann, Laura C Zelarayan, and Maria-Patapia Zafeiriou 
264 1 |c 2021 
300 |a 15 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Online publish-ahead-of-print 10 August 2020 
500 |a Gesehen am 22.03.2022 
520 |a Arrhythmias and sudden cardiac death (SCD) occur commonly in patients with heart failure. We found T-box 5 (TBX5) dysregulated in ventricular myocardium from heart failure patients and thus we hypothesized that TBX5 reduction contributes to arrhythmia development in these patients. To understand the underlying mechanisms, we aimed to reveal the ventricular TBX5-dependent transcriptional network and further test the therapeutic potential of TBX5 level normalization in mice with documented arrhythmias.We used a mouse model of TBX5 conditional deletion in ventricular cardiomyocytes. Ventricular (v) TBX5 loss in mice resulted in mild cardiac dysfunction and arrhythmias and was associated with a high mortality rate (60%) due to SCD. Upon angiotensin stimulation, vTbx5KO mice showed exacerbated cardiac remodelling and dysfunction suggesting a cardioprotective role of TBX5. RNA-sequencing of a ventricular-specific TBX5KO mouse and TBX5 chromatin immunoprecipitation was used to dissect TBX5 transcriptional network in cardiac ventricular tissue. Overall, we identified 47 transcripts expressed under the control of TBX5, which may have contributed to the fatal arrhythmias in vTbx5KO mice. These included transcripts encoding for proteins implicated in cardiac conduction and contraction (Gja1, Kcnj5, Kcng2, Cacna1g, Chrm2), in cytoskeleton organization (Fstl4, Pdlim4, Emilin2, Cmya5), and cardiac protection upon stress (Fhl2, Gpr22, Fgf16). Interestingly, after TBX5 loss and arrhythmia development in vTbx5KO mice, TBX5 protein-level normalization by systemic adeno-associated-virus (AAV) 9 application, re-established TBX5-dependent transcriptome. Consequently, cardiac dysfunction was ameliorated and the propensity of arrhythmia occurrence was reduced.This study uncovers a novel cardioprotective role of TBX5 in the adult heart and provides preclinical evidence for the therapeutic value of TBX5 protein normalization in the control of arrhythmia. 
700 1 |a Blenkle, Alica  |e VerfasserIn  |4 aut 
700 1 |a Iyer, Lavanya M  |e VerfasserIn  |4 aut 
700 1 |a Renger, Anke  |e VerfasserIn  |4 aut 
700 1 |a Syeda, Fahima  |e VerfasserIn  |4 aut 
700 1 |a Noack, Claudia  |e VerfasserIn  |4 aut 
700 1 |a Jungmann, Andreas  |d 1976-  |e VerfasserIn  |0 (DE-588)135606454  |0 (DE-627)56859455X  |0 (DE-576)300540884  |4 aut 
700 1 |a Dewenter, Matthias  |e VerfasserIn  |0 (DE-588)1148565558  |0 (DE-627)1008763721  |0 (DE-576)496327763  |4 aut 
700 1 |a Toischer, Karl  |d 1978-  |e VerfasserIn  |0 (DE-588)137372825  |0 (DE-627)695068504  |0 (DE-576)303210060  |4 aut 
700 1 |a El-Armouche, Ali  |e VerfasserIn  |4 aut 
700 1 |a Müller, Oliver J.  |d 1971-  |e VerfasserIn  |0 (DE-588)121693449  |0 (DE-627)705619621  |0 (DE-576)292833504  |4 aut 
700 1 |a Fabritz, Larissa  |e VerfasserIn  |4 aut 
700 1 |a Zimmermann, Wolfram-Hubertus  |e VerfasserIn  |4 aut 
700 1 |a Zelarayan, Laura C  |e VerfasserIn  |4 aut 
700 1 |a Zafeiriou, Maria-Patapia  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Cardiovascular research  |d Oxford : Oxford University Press, 1967  |g 117(2021), 8, Seite 1908-1922  |h Online-Ressource  |w (DE-627)306654393  |w (DE-600)1499917-1  |w (DE-576)081984685  |x 1755-3245  |7 nnas  |a Preclinical evidence for the therapeutic value of TBX5 normalization in arrhythmia control 
773 1 8 |g volume:117  |g year:2021  |g number:8  |g pages:1908-1922  |g extent:15  |a Preclinical evidence for the therapeutic value of TBX5 normalization in arrhythmia control 
856 4 0 |u https://doi.org/10.1093/cvr/cvaa239  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20220322 
993 |a Article 
994 |a 2021 
998 |g 121693449  |a Müller, Oliver J.  |m 121693449:Müller, Oliver J.  |d 50000  |e 50000PM121693449  |k 0/50000/  |p 11 
998 |g 135606454  |a Jungmann, Andreas  |m 135606454:Jungmann, Andreas  |d 910000  |d 910100  |e 910000PJ135606454  |e 910100PJ135606454  |k 0/910000/  |k 1/910000/910100/  |p 8 
998 |g 1148565558  |a Dewenter, Matthias  |m 1148565558:Dewenter, Matthias  |d 910000  |d 910100  |e 910000PD1148565558  |e 910100PD1148565558  |k 0/910000/  |k 1/910000/910100/  |p 7 
999 |a KXP-PPN1796310611  |e 4097659146 
BIB |a Y 
SER |a journal 
JSO |a {"note":["Online publish-ahead-of-print 10 August 2020","Gesehen am 22.03.2022"],"relHost":[{"origin":[{"publisher":"Oxford University Press ; Elsevier Science","dateIssuedDisp":"1967-","dateIssuedKey":"1967","publisherPlace":"Oxford ; Amsterdam [u.a.]"}],"title":[{"title":"Cardiovascular research","title_sort":"Cardiovascular research"}],"physDesc":[{"extent":"Online-Ressource"}],"part":{"volume":"117","text":"117(2021), 8, Seite 1908-1922","pages":"1908-1922","year":"2021","issue":"8","extent":"15"},"id":{"eki":["306654393"],"issn":["1755-3245"],"zdb":["1499917-1"]},"note":["Gesehen am 01.12.2020"],"disp":"Preclinical evidence for the therapeutic value of TBX5 normalization in arrhythmia controlCardiovascular research","recId":"306654393","language":["eng"],"type":{"media":"Online-Ressource","bibl":"periodical"},"pubHistory":["1.1967 -"]}],"id":{"doi":["10.1093/cvr/cvaa239"],"eki":["1796310611"]},"type":{"bibl":"article-journal","media":"Online-Ressource"},"physDesc":[{"extent":"15 S."}],"title":[{"title":"Preclinical evidence for the therapeutic value of TBX5 normalization in arrhythmia control","title_sort":"Preclinical evidence for the therapeutic value of TBX5 normalization in arrhythmia control"}],"language":["eng"],"origin":[{"dateIssuedDisp":"2021","dateIssuedKey":"2021"}],"name":{"displayForm":["Franziska S Rathjens, Alica Blenkle, Lavanya M Iyer, Anke Renger, Fahima Syeda, Claudia Noack, Andreas Jungmann, Matthias Dewenter, Karl Toischer, Ali El-Armouche, Oliver J Müller, Larissa Fabritz, Wolfram-Hubertus Zimmermann, Laura C Zelarayan, and Maria-Patapia Zafeiriou"]},"recId":"1796310611","person":[{"family":"Rathjens","display":"Rathjens, Franziska S.","given":"Franziska S.","role":"aut"},{"given":"Alica","display":"Blenkle, Alica","family":"Blenkle","role":"aut"},{"family":"Iyer","display":"Iyer, Lavanya M","given":"Lavanya M","role":"aut"},{"role":"aut","family":"Renger","given":"Anke","display":"Renger, Anke"},{"role":"aut","display":"Syeda, Fahima","given":"Fahima","family":"Syeda"},{"role":"aut","given":"Claudia","display":"Noack, Claudia","family":"Noack"},{"given":"Andreas","display":"Jungmann, Andreas","family":"Jungmann","role":"aut"},{"role":"aut","family":"Dewenter","display":"Dewenter, Matthias","given":"Matthias"},{"given":"Karl","display":"Toischer, Karl","family":"Toischer","role":"aut"},{"role":"aut","family":"El-Armouche","given":"Ali","display":"El-Armouche, Ali"},{"role":"aut","display":"Müller, Oliver J.","given":"Oliver J.","family":"Müller"},{"role":"aut","family":"Fabritz","given":"Larissa","display":"Fabritz, Larissa"},{"family":"Zimmermann","display":"Zimmermann, Wolfram-Hubertus","given":"Wolfram-Hubertus","role":"aut"},{"role":"aut","family":"Zelarayan","display":"Zelarayan, Laura C","given":"Laura C"},{"role":"aut","given":"Maria-Patapia","display":"Zafeiriou, Maria-Patapia","family":"Zafeiriou"}]} 
SRT |a RATHJENSFRPRECLINICA2021